Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)
China · Delayed Price · Currency is CNY 19.15
+0.75 (4.08%)
At close: Mar 6, 2026
SHA:688670 Market Cap
SHA:688670 has a market cap or net worth of 2.36 billion as of March 6, 2026. Its market cap has increased by 54.56% in one year.
Market Cap
2.36B
Enterprise Value
2.26B
Revenue
113.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.15
Market Cap Chart
Since August 2, 2021, SHA:688670's market cap has decreased from 7.30B to 2.36B, a decrease of -67.66%. That is a compound annual growth rate of -21.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.36B | -5.34% |
| Dec 31, 2025 | 2.49B | 66.91% |
| Dec 31, 2024 | 1.49B | -57.41% |
| Dec 29, 2023 | 3.51B | -7.32% |
| Dec 30, 2022 | 3.78B | -43.20% |
| Dec 31, 2021 | 6.66B | -8.72% |
| Aug 2, 2021 | 7.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novoprotein Scientific | 2.83B |
| Shanghai Universal Biotech | 2.68B |
| Jilin Jian Yisheng Pharmaceutical | 2.64B |
| Shandong Sito Bio-technology | 2.61B |
| Shanghai Serum Bio-Technology | 2.53B |
| Jiangsu CoWin Biotech | 2.52B |
| Zhejiang East Asia Pharmaceutical | 2.41B |
| Guiyang Xintian Pharmaceutical | 2.36B |